サマリー

百日咳ワクチンとは、百日咳を予防するためのワクチンです。大きく分けて、全細胞型ワクチンと細胞型ワクチンの2種類があります。ホールセルワクチンの効果は約78％、アセラーワクチンの効果は71～85％です。
市場の分析と洞察百日咳ワクチンの世界市場
COVID-19の大流行により、百日咳ワクチンの世界市場規模は2022年に5億3,849万米ドルと推定され、レビュー期間中のCAGR3.5％で2028年までに6億6,194万米ドルに再調整されると予測されています。この健康危機による経済変化を十分に考慮し、2021年に百日咳ワクチンの世界市場の％を占めたホールセルワクチンは、2028年までに100万米ドルの価値を持ち、ポストCOVID-19期間に改訂された％のCAGRで成長すると予測されます。12ヶ月以下セグメントは、この予測期間を通して％CAGRに変更されている一方で。
世界の百日咳ワクチンの主要企業は、Sanofi Pasteur、GSK、田辺三菱製薬、Wuhan Institute of Biological Products、Walvax Biotechnologyなどです。世界の上位2社で約90％のシェアを占めています。欧州が30%以上のシェアを持つ最大市場であり、北米がこれに次ぐ。
百日咳ワクチンの世界的な範囲とセグメント
百日咳ワクチン市場は、タイプ別および用途別に分類されます。百日咳ワクチンの世界市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができます。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の売上、収益、予測に焦点を当てています。
タイプ別セグメント
ホールセルワクチン
アセロラワクチン
アプリケーション別セグメント
12ヶ月未満
12ヶ月以上
会社別
サノフィパスツール
GSK
田辺三菱製薬
武漢生物学製品研究所
ウォルバックス・バイオテクノロジー
ミンハイバイオテクノロジー
KMバイオロジックス
成都生物学製品研究所
地域別
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
U.A.E.

ページTOPに戻る

目次

1 Study Coverage
1.1 Pertussis Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pertussis Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Whole-cell Vaccines
1.2.3 Acellular Vaccines
1.3 Market by Application
1.3.1 Global Pertussis Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pertussis Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Pertussis Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Pertussis Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pertussis Vaccine Sales by Region
2.4.1 Global Pertussis Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Pertussis Vaccine by Region (2023-2028)
2.5 Global Pertussis Vaccine Revenue by Region
2.5.1 Global Pertussis Vaccine Revenue by Region (2017-2022)
2.5.2 Global Pertussis Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pertussis Vaccine Sales by Manufacturers
3.1.1 Global Top Pertussis Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Pertussis Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pertussis Vaccine in 2021
3.2 Global Pertussis Vaccine Revenue by Manufacturers
3.2.1 Global Pertussis Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Pertussis Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pertussis Vaccine Revenue in 2021
3.3 Global Pertussis Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pertussis Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pertussis Vaccine Sales by Type
4.1.1 Global Pertussis Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Pertussis Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Pertussis Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Pertussis Vaccine Revenue by Type
4.2.1 Global Pertussis Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Pertussis Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pertussis Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Pertussis Vaccine Price by Type
4.3.1 Global Pertussis Vaccine Price by Type (2017-2022)
4.3.2 Global Pertussis Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pertussis Vaccine Sales by Application
5.1.1 Global Pertussis Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Pertussis Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Pertussis Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Pertussis Vaccine Revenue by Application
5.2.1 Global Pertussis Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Pertussis Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pertussis Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Pertussis Vaccine Price by Application
5.3.1 Global Pertussis Vaccine Price by Application (2017-2022)
5.3.2 Global Pertussis Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pertussis Vaccine Market Size by Type
6.1.1 North America Pertussis Vaccine Sales by Type (2017-2028)
6.1.2 North America Pertussis Vaccine Revenue by Type (2017-2028)
6.2 North America Pertussis Vaccine Market Size by Application
6.2.1 North America Pertussis Vaccine Sales by Application (2017-2028)
6.2.2 North America Pertussis Vaccine Revenue by Application (2017-2028)
6.3 North America Pertussis Vaccine Market Size by Country
6.3.1 North America Pertussis Vaccine Sales by Country (2017-2028)
6.3.2 North America Pertussis Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Pertussis Vaccine Market Size by Type
7.1.1 Europe Pertussis Vaccine Sales by Type (2017-2028)
7.1.2 Europe Pertussis Vaccine Revenue by Type (2017-2028)
7.2 Europe Pertussis Vaccine Market Size by Application
7.2.1 Europe Pertussis Vaccine Sales by Application (2017-2028)
7.2.2 Europe Pertussis Vaccine Revenue by Application (2017-2028)
7.3 Europe Pertussis Vaccine Market Size by Country
7.3.1 Europe Pertussis Vaccine Sales by Country (2017-2028)
7.3.2 Europe Pertussis Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pertussis Vaccine Market Size by Type
8.1.1 Asia Pacific Pertussis Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Pertussis Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Pertussis Vaccine Market Size by Application
8.2.1 Asia Pacific Pertussis Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Pertussis Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Pertussis Vaccine Market Size by Region
8.3.1 Asia Pacific Pertussis Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Pertussis Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Pertussis Vaccine Market Size by Type
9.1.1 Latin America Pertussis Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Pertussis Vaccine Revenue by Type (2017-2028)
9.2 Latin America Pertussis Vaccine Market Size by Application
9.2.1 Latin America Pertussis Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Pertussis Vaccine Revenue by Application (2017-2028)
9.3 Latin America Pertussis Vaccine Market Size by Country
9.3.1 Latin America Pertussis Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Pertussis Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pertussis Vaccine Market Size by Type
10.1.1 Middle East and Africa Pertussis Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pertussis Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Pertussis Vaccine Market Size by Application
10.2.1 Middle East and Africa Pertussis Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pertussis Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Pertussis Vaccine Market Size by Country
10.3.1 Middle East and Africa Pertussis Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pertussis Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Corporation Information
11.1.2 Sanofi Pasteur Overview
11.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Pasteur Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Pasteur Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Mitsubishi Tanabe Pharma
11.3.1 Mitsubishi Tanabe Pharma Corporation Information
11.3.2 Mitsubishi Tanabe Pharma Overview
11.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mitsubishi Tanabe Pharma Recent Developments
11.4 Wuhan Institute of Biological Products
11.4.1 Wuhan Institute of Biological Products Corporation Information
11.4.2 Wuhan Institute of Biological Products Overview
11.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Wuhan Institute of Biological Products Recent Developments
11.5 Walvax Biotechnology
11.5.1 Walvax Biotechnology Corporation Information
11.5.2 Walvax Biotechnology Overview
11.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Walvax Biotechnology Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Walvax Biotechnology Recent Developments
11.6 Minhai Biotechnology
11.6.1 Minhai Biotechnology Corporation Information
11.6.2 Minhai Biotechnology Overview
11.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Minhai Biotechnology Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Minhai Biotechnology Recent Developments
11.7 KM Biologics
11.7.1 KM Biologics Corporation Information
11.7.2 KM Biologics Overview
11.7.3 KM Biologics Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 KM Biologics Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 KM Biologics Recent Developments
11.8 Chengdu Institute of Biological Products
11.8.1 Chengdu Institute of Biological Products Corporation Information
11.8.2 Chengdu Institute of Biological Products Overview
11.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Chengdu Institute of Biological Products Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pertussis Vaccine Industry Chain Analysis
12.2 Pertussis Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pertussis Vaccine Production Mode & Process
12.4 Pertussis Vaccine Sales and Marketing
12.4.1 Pertussis Vaccine Sales Channels
12.4.2 Pertussis Vaccine Distributors
12.5 Pertussis Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pertussis Vaccine Industry Trends
13.2 Pertussis Vaccine Market Drivers
13.3 Pertussis Vaccine Market Challenges
13.4 Pertussis Vaccine Market Restraints
14 Key Findings in The Global Pertussis Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer